![Emily Anne Scraggs](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Emily Anne Scraggs
Director/Miembro de la Junta en Talisman Therapeutics Ltd. .
Cargos activos de Emily Anne Scraggs
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Talisman Therapeutics Ltd.
![]() Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Director/Miembro de la Junta | - | - |
Corporate Officer/Principal | - | - |
Historial de carrera de Emily Anne Scraggs
Antiguos cargos conocidos de Emily Anne Scraggs.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Gen2 Neuroscience Ltd.
![]() Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Director/Miembro de la Junta | 07/01/2016 | - |
Fundador | 07/01/2016 | - |
Estadísticas
Internacional
Reino Unido | 3 |
Operativa
Director/Board Member | 2 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Gen2 Neuroscience Ltd.
![]() Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Talisman Therapeutics Ltd.
![]() Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Emily Anne Scraggs
- Experiencia